Sanjai Kumar, Ph.D. - Publications

Affiliations: 
2002 Wesleyan University, Middletown, CT, United States 
Area:
Biochemistry, Organic Chemistry

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wardman JH, Gomes I, Bobeck EN, Stockert JA, Kapoor A, Bisignano P, Gupta A, Mezei M, Kumar S, Filizola M, Devi LA. Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake. Science Signaling. 9: ra55. PMID 27245612 DOI: 10.1126/scisignal.aac8035  0.68
2015 Blazekovic F, Odukoya D, Butler SN, Mauro JA, Ramsamooj M, Puleo E, Szekeres K, Dana D, Kumar S, Ragupathi G, Blanck G. HLA-DR peptide occupancy can be regulated with a wide variety of small molecules. Human Vaccines & Immunotherapeutics. 0. PMID 26453454 DOI: 10.1080/21645515.2015.1089370  0.68
2014 Ho HP, Rathod P, Louis M, Tada CK, Rahaman S, Mark KJ, Leng J, Dana D, Kumar S, Lichterfeld M, Chang EJ. Studies on quantitative phosphopeptide analysis by matrix-assisted laser desorption/ionization mass spectrometry without label, chromatography or calibration curves. Rapid Communications in Mass Spectrometry : Rcm. 28: 2681-9. PMID 25380489 DOI: 10.1002/rcm.7063  0.68
2014 Dana D, De S, Rathod P, Davalos AR, Novoa DA, Paroly S, Torres VM, Afzal N, Lankalapalli RS, Rotenberg SA, Chang EJ, Subramaniam G, Kumar S. Development of a highly potent, selective, and cell-active inhibitor of cysteine cathepsin L-A hybrid design approach. Chemical Communications (Cambridge, England). 50: 10875-8. PMID 25089379 DOI: 10.1039/c4cc04037f  0.68
2013 Gomes I, Aryal DK, Wardman JH, Gupta A, Gagnidze K, Rodriguiz RM, Kumar S, Wetsel WC, Pintar JE, Fricker LD, Devi LA. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proceedings of the National Academy of Sciences of the United States of America. 110: 16211-6. PMID 24043826 DOI: 10.1073/pnas.1312938110  0.68
2013 Dana D, Davalos AR, De S, Rathod P, Gamage RK, Huestis J, Afzal N, Zavlanov Y, Paroly SS, Rotenberg SA, Subramaniam G, Mark KJ, Chang EJ, Kumar S. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins. Bioorganic & Medicinal Chemistry. 21: 2975-87. PMID 23623677 DOI: 10.1016/j.bmc.2013.03.062  0.68
2013 Patel BA, Krishnan R, Khadtare N, Gurukumar KR, Basu A, Arora P, Bhatt A, Patel MR, Dana D, Kumar S, Kaushik-Basu N, Talele TT. Design and synthesis of L- and D-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry. 21: 3262-71. PMID 23598249 DOI: 10.1016/j.bmc.2013.03.041  0.68
2012 Dana D, Das TK, Kumar I, Davalos AR, Mark KJ, Ramai D, Chang EJ, Talele TT, Kumar S. Design, synthesis, and evaluation of 2-(arylsulfonyl)oxiranes as cell-permeable covalent inhibitors of protein tyrosine phosphatases. Chemical Biology & Drug Design. 80: 489-99. PMID 22726577 DOI: 10.1111/j.1747-0285.2012.01437.x  0.68
2008 Lee JH, Kumar S, Lawrence DS. Stepwise combinatorial evolution of Akt bisubstrate inhibitors. Chembiochem : a European Journal of Chemical Biology. 9: 507-9. PMID 18224646 DOI: 10.1002/cbic.200700583  0.68
2007 Dai Z, Dulyaninova NG, Kumar S, Bresnick AR, Lawrence DS. Visual snapshots of intracellular kinase activity at the onset of mitosis. Chemistry & Biology. 14: 1254-60. PMID 18022564 DOI: 10.1016/j.chembiol.2007.10.007  0.68
2007 Zhang S, Chen L, Kumar S, Wu L, Lawrence DS, Zhang ZY. An affinity-based fluorescence polarization assay for protein tyrosine phosphatases. Methods (San Diego, Calif.). 42: 261-7. PMID 17532513 DOI: 10.1016/j.ymeth.2007.02.008  0.68
2005 Kumar S, Liang F, Lawrence DS, Zhang ZY. Small molecule approach to studying protein tyrosine phosphatase. Methods (San Diego, Calif.). 35: 9-21. PMID 15588981 DOI: 10.1016/j.ymeth.2004.07.003  0.68
2004 Kumar S, Adediran SA, Nukaga M, Pratt RF. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics. Biochemistry. 43: 2664-72. PMID 14992604 DOI: 10.1021/bi030212j  0.68
2004 Nukaga M, Kumar S, Nukaga K, Pratt RF, Knox JR. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes. The Journal of Biological Chemistry. 279: 9344-52. PMID 14660590 DOI: 10.1074/jbc.M312356200  0.68
2001 Kumar S, Pearson AL, Pratt RF. Design, synthesis, and evaluation of alpha-ketoheterocycles as class C beta-lactamase inhibitors. Bioorganic & Medicinal Chemistry. 9: 2035-44. PMID 11504640 DOI: 10.1016/S0968-0896(01)00107-9  0.68
Show low-probability matches.